Names | |
---|---|
Preferred IUPAC name
1-{3-[4-(Piperidin-1-ylmethyl)phenoxy]propyl}piperidine
|
|
Systematic IUPAC name
1-({4-[3-(Piperidin-1-yl)propoxy]phenyl}methyl)piperidine
|
|
Identifiers | |
3D model (JSmol)
|
|
Abbreviations | JNJ-5207852 |
ChEBI | |
ChemSpider | |
MeSH | JNJ-5207852 |
PubChem CID
|
|
|
|
|
|
Properties | |
C20H32N2O | |
Molar mass | 316.480 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
JNJ-5207852 is a histamine antagonist selective for the H3 subtype. It has stimulant and nootropic effects in animal studies, and has been suggested as a possible treatment for memory defects associated with epilepsy. JNJ-5207852 itself did not progress to clinical development due to poor pharmacokinetic characteristics, but the related compound JNJ-17216498 is currently in Phase II clinical trials for the treatment of narcolepsy.